The Human Urine Metabolome

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Bouatra, Souhaila ^a   Aziat, Farid ^a   Mandal, Rupasri ^a   Guo, An Chi ^a   Wilson, Michael R ^a   Knox, Craig ^a   Bjorndahl, Trent C ^a   Krishnamurthy, Ramanarayan ^a   Saleem, Fozia ^a   Liu, Philip ^a   Dame, Zerihun T ^a   Poelzer, Jenna ^a   Huynh, Jessica ^a   Yallou, Faizath S ^a   Psychogios, Nick ^b   Dong, Edison ^a   Bogumil, Ralf ^c   Roehring, Cornelia ^c   Wishart, David S ^a,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BIOCRATES LIFE SCIENCES AG   (Austria)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; COMPUTER ANALYSIS; DATA BASE; DIRECT FLOW INJECTION MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONLINE ANALYSIS; QUANTITATIVE ANALYSIS; URINALYSIS; URINE LEVEL; VALIDATION STUDY;

DATABASES, FACTUAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; URINALYSIS;

EID: 84883331522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073076     Document Type: Article

References (120)

1. Bundy JG, Davey MP, Viant MR, (2009) Environmental metabolomics: a critical review and future perspectives. Metabolomics 5: 3-21.
2. Montoliu I, Genick U, Ledda M, Collino S, Martin FP, et al. (2013) Current status on genome-metabolome-wide associations: an opportunity in nutrition research. Genes Nutr 8: 19-27.
3. Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, et al. (2012) Metabolic phenotyping in clinical and surgical environments. Nature 491: 384-392.
4. Viant MR, (2008) Recent developments in environmental metabolomics. Mol Biosyst 4: 980-986.
5. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, et al. (2003) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 9: 477-477.
6. Dunne VG, Bhattachayya S, Besser M, Rae C, Griffin JL, (2005) Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition H-1 NMR study. NMR Biomed 18: 24-33.
7. Kaddurah-Daouk R, Beecher C, kristal B, Maston W, Bogdanov M, (2004) Bioanalytical advances for metabolomics and metabolic profiling. Pharmagenomics 4: 46-52.
8. Mendrick DL, Schnackenberg L, (2009) Genomic and metabolomic advances in the identification of disease and adverse event biomarkers. Biomark Med 3: 605-615.
9. Ng DJY, Pasikanti KK, Chan ECY, (2011) Trend analysis of metabonomics and systematic review of metabonomics-derived cancer marker metabolites. Metabolomics 7: 155-178.
10. Wishart DS, (2008) Applications of metabolomics in drug discovery and development. Drugs R D 9: 307-322.
11. Lim C, Kim J, Choi JN, Ponnusamy K, Jeon Y, et al. (2010) Identification, fermentation, and bioactivity against xanthomonas oryzae of antimicrobial metabolites isolated from phomopsis longicolla S1B4. J Microbiol Biotechn 20: 494-500.
12. Metz TO, Zhang QB, Page JS, Shen YF, Callister SJ, et al. (2007) Future of liquid chromatography-mass spectrometry in metabolic profiling and metabolomic studies for biomarker discovery. Biomark Med 1: 159-185.
13. Rousu T, Pelkonen O, Tolonen A, (2009) Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 23: 843-855.
14. Zhang W, Saif MW, Dutschman GE, Li X, Lam W, et al. (2010) Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS). J Chromatogr A 1217: 5785-5793.
15. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, et al. (2013) HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res 41: D801-D807.
16. Wishart DS, Knox C, Guo AC, Eisner R, Young N, et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37: D603-D610.
17. Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, et al. (2008) The human cerebrospinal fluid metabolome. J Chromatogr B 871: 164-173.
18. Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, et al. (2012) Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 4: 38-49.
19. Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, et al. (2009) Understanding the human salivary metabolome. NMR Biomed 22: 577-584.
20. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, et al. (2011) The Human Serum Metabolome. Plos One 6 (2): e16957.
21. Echeverry G, Hortin GL, Rai AJ, (2010) Introduction to urinalysis: historical perspectives and clinical application. Methods Mol Biol 641: 1-12.
22. Kouba E, Wallen EM, Pruthi RS, (2007) Uroscopy by hippocrates and theophilus: prognosis versus diagnosis. J Urology 177: 50-52.
23. Pardalidis N, Kosmaoglou E, Diamantis A, Sofikitis N, (2008) Uroscopy in byzantium. J Urology 179: 1271-1276.
24. Rigby D, Gray K (2005) Understanding urine testing. 60-62 p.
25. Nicholson JK, Lindon JC, (2008) Systems biology- metabonomics. Nature 455: 1054-1056.
26. Garrod AE, (1996) The incidence of alkaptonuria: a study in chemical individuality. Mol Med 2: 274-282.
27. Issaq HJ, Nativ O, Waybright T, Luke B, Veenstra TD, et al. (2008) Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry. J Urology 179: 2422-2426.
28. Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, et al. (2009) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8: 558-570.
29. Kind T, Tolstikov V, Fiehn O, Weiss RH, (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363: 185-195.
30. Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, et al. (2010) Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res 9: 2988-2995.
31. Want EJ, Wilson ID, Gika H, Theodoridis G, Plumb RS, et al. (2010) Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5: 1005-1018.
32. Zhang Y, Tobias HJ, Auchus RJ, Brenna JT, (2011) Comprehensive 2-dimensional gas chromatography fast quadrupole mass spectrometry (GC x GC-qMS) for urinary steroid profiling: Mass spectral characteristics with chemical ionization. Drug Test Anal 3: 857-867.
33. Kim H, Ahn E, Moon MH, (2008) Profiling of human urinary phospholipids by nanoflow liquid chromatography/tandem mass spectrometry. Analyst 133: 1656-1663.
34. Law WS, Huang PY, Ong ES, Ong CN, Li SFY, et al. (2008) Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and H-1 NMR spectroscopy. Rapid Commun Mass Spectrom 22: 2436-2446.
35. Luo JL, Lamb JH, Lim CK, (1997) Analysis of urinary and faecal porphyrin excretion patterns in human porphyrias by fast atom bombardment mass spectrometry. J Pharmaceut Biomed 15: 1289-1294.
36. Nielen MWF, Bovee TFH, van Engelen MC, Rutgers P, Hamers ARM, et al. (2006) Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification. Anal Chem 78: 424-431.
37. Wadhier MC, Almstetter MF, Nurnberger N, Gruber MA, Dettmer K, et al. (2011) Improved enantiomer resolution and quantification of free D-amino acids in serum and urine by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry. J Chromatogr A 1218: 4537-4544.
38. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E, (2005) NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 18: 143-162.
39. Lindon JC, Keun HC, Ebbels TMD, Pearce JMT, Holmes E, et al. (2005) The consortium for metabonomic toxicology (comet): aims, activities and achievements. Pharmacogenomics 6: 691-699.
40. Yang WJ, Wang YW, Zhou QF, Tang HR, (2008) Analysis of human urine metabolites using SPE and NMR spectroscopy. Sci China Ser B 51: 218-225.
41. Minkler PE, Hoppel CL, (1993) Quantification of carnitine and specific acylcarnitines by high-performance liquid-chromatography- application to normal human urine and urine from patients with methylmalonic aciduria, isovaleric acidemia or medium-chain acyl-coa dehydrogenase-deficiency. J Chromatogr-Biomed 613: 203-221.
42. Navarro-Munoz M, Ibernon M, Bonet J, Perez V, Pastor MC, et al. (2012) Uromodulin and alpha(1)-Antitrypsin Urinary Peptide Analysis to Differentiate Glomerular Kidney Diseases. Kidney Blood Press Res 35: 314-325.
43. Giron AJ, Deventer K, Roels K, Van Eenoo P, (2012) Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. Anal Chim Acta 721: 137-146.
44. Yanamandra R, Vadla CS, Puppala U, Patro B, Murthy YL, et al. (2012) A new rapid and sensitive stability-Indicating UPLC assay method for tolterodine tartrate: application in pharmaceuticals, human plasma and urine samples. Sci Pharm 80: 101-114.
45. Kanehisa M, (2002) The KEGG database. Novart Fdn Symp 247: 91-103.
46. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2006) Database resources of the national center for biotechnology information. Nucleic Acids Res 34: D173-D180.
47. Caspi R, Foerster H, Fulcher CA, Hopkinson R, Ingraham J, et al. (2006) MetaCyc: a multiorganism database of metabolic pathways and enzymes. Nucleic Acids Res 34: D511-D516.
48. Degtyarenko K, De Matos P, Ennis M, Hastings J, Zbinden M, et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res 36: D344-D350.
49. Maccarone MC, Tripicano M, Digesu V, Tegolo D, (1993) PDB- a Pictorial Database Oriented to data-analysis. Software Pract Exper 23: 55-73.
50. Bairoch A, Bougueleret L, Altairac S, Amendolia V, Auchincloss A, et al. (2008) The Universal Protein Resource (UniProt). Nucleic Acids Res 36: D190-D195.
51. Ouellette BFF, (1998) The GenBank sequence database. Bioinformatics 39: 16-45.
52. Safran M, Dalah I, Alexander J, Rosen N, Stein TI, et al. (2010) GeneCards Version 3: the human gene integrator. Database-Oxford 10: 1093/baq1020.
53. Kapushesky M, Adamusiak T, Burdett T, Culhane A, Farne A, et al. (2012) Gene Expression Atlas update-a value-added database of microarray and sequencing-based functional genomics experiments. Nucleic Acids Res 40: D1077-D1081.
54. Bruford EA, Lush MJ, Wright MW, Sneddon TP, Povey S, et al. (2008) The HGNC database in 2008: a resource for the human genome. Nucleic Acids Res 36: D445-D448.
55. Frolkis A, Knox C, Lim E, Jewison T, Law V, et al. (2010) SMPDB: The Small Molecule Pathway Database. Nucleic Acids Res 38: D480-D487.
56. Guneral F, Bachmann C, (1994) Age-related reference values for urinary organic-acids in a healthy turkish pediatric population. Clin Chem 40: 862-868.
57. Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET, (2008) Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed 21: 195-207.
58. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, et al. (2007) Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79: 6995-7004.
59. Zuppi C, Messana I, Forni F, Rossi C, Pennacchietti L, et al. (1997) H-1 NMR spectra of normal urines: Reference ranges of the major metabolites. Clin Chim Acta 265: 85-97.
60. Hao J, Astle W, De Iorio M, Ebbels TMD, (2012) BATMAN-an R package for the automated quantification of metabolites from nuclear magnetic resonance spectra using a Bayesian model. Bioinformatics 28: 2088-2090.
61. Kern SM, Bennett RN, Mellon FA, Kroon PA, Garcia-Conesa MT, (2003) Absorption of hydroxycinnamates in humans after high-bran cereal consumption. J Agr Food Chem 51: 6050-6055.
62. Rios LY, Gonthier MP, Remesy C, Mila L, Lapierre C, et al. (2003) Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am J Clin Nutr 77: 912-918.
63. Lloyd AJ, Beckmann M, Fave G, Mathers JC, Draper J, (2011) Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br J Nutr 106: 812-824.
64. Atkinson W, Downer P, Lever M, Chambers ST, George PM, (2007) Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects. Eur J Nutr 46: 446-452.
65. Hucker HB, Miller JK, Hochberg A, Brobyn RD, Riordan FH, et al. (1967) Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. J Pharm Exp Ther 155: 309-317.
66. Winning H, Roldan-Marin E, Dragsted LO, Viereck N, Poulsen M, et al. (2009) An exploratory NMR nutri-metabonomic investigation reveals dimethyl sulfone as a dietary biomarker for onion intake. Analyst 134: 2344-2351.
67. Kumari K, Augusti KT, (2007) Lipid lowering effect of S-methyl cysteine sulfoxide from Allium cepa Linn in high cholesterol diet fed rats. J Ethnopharmacol 109: 367-371.
68. Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, et al. (2000) Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol 152: 752-755.
69. Sjolin J, Hjort G, Friman G, Hambraeus L, (1987) Urinary excretion of 1-methylhistidine: a qualitative indicator of exogenous 3-methylhistidine and intake of meats from various sources. Metabolism 36: 1175-1184.
70. Sjolin J, Stjernstrom H, Henneberg S, Hambraeus L, Friman G, (1989) Evaluation of urinary 3-methylhistidine excretion in infection by measurements of 1-methylhistidine and the creatinine ratios. Am J Clin Nutr 49: 62-70.
71. Rubin D, (1979) Free glucuronic acid in urine as estimate of tumor load. Clin Chem 25: 1867-1868.
72. Dutton GJ (1966) Glucuronic Acid, Free and Combined: Chemistry, Biochemistry, Pharmacology, and Medicine. Madison: Academic Press. 629.
73. Smith LM, Maher AD, Cloarec O, Rantalainen M, Tang H, et al. (2007) Statistical correlation and projection methods for improved information recovery from diffusion-edited NMR spectra of biological samples. Anal Chem 79: 5682-5689.
74. Rodriguez-Concepcion M, Boronat A, (2002) Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics. Plant Physiol 130: 1079-1089.
75. Dittrich P, Angyal SJ, (1988) 2-C-methyl-D-erythritol in leaves of Liriodendron tulipifera. Phytochemistry 27: 935.
76. Kang SM, Park JC, Shin MJ, Lee H, Oh J, et al. (2011) H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clin Biochem 44: 293-299.
77. Engelke UF, Liebrand-van Sambeek ML, De Jong JG, Leroy JG, Morava E, et al. (2004) N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin Chem 50: 58-66.
78. Rezzi S, Vera FA, Martin FPJ, Wang S, Lawler D, et al. (2008) Automated SPE-RP-HPLC fractionation of biofluids combined to off-line NMR spectroscopy for biomarker identification in metabonomics. J Chromatogr B 871: 271-278.
79. Saude EJ, Slupsky CM, Sykes BD, (2006) Optimization of NMR analysis of biological fluids for quantitative accuracy. Metabolomics 2: 113-123.
80. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29: 99-108.
81. Pechlivanis A, Kostidis S, Saraslanidis P, Petridou A, Tsalis G, et al. (2010) H-1 NMR-Based Metabonomic Investigation of the Effect of Two Different Exercise Sessions on the Metabolic Fingerprint of Human Urine. J Proteome Res 9: 6405-6416.
82. Taylor EH (1989) Clinical Chemistry. New York: John Wiley and Sons. 293 p.
83. Roux A, Xu Y, Heilier JF, Olivier MF, Ezan E, et al. (2012) Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-Orbitrap mass spectrometer. Anal Chem 84: 6429-6437.
84. Shoemaker JD, Elliott WH, (1991) Automated screening of urine samples for carbohydrates, organic and amino-acids after treatment with urease. J Chromatogr-Biomed 562: 125-138.
85. Lawson AM, Chalmers RA, Watts RWE, (1976) Urinary organic-acids in man. I. normal patterns. Clin Chem 22: 1283-1287.
86. Pasikanti KK, Ho PC, Chan ECY, (2008) Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Commun Mass Sp 22: 2984-2992.
87. Röhring C, Bogumil R, Dammeier S. Analysis of human urine using the absolute IDQ™ Kit Application Note 1003-1 Innsbruck, Austria: Biocrates Life Sciences Available At: http://wwwbiocratescom/images/stories/pdf/biocrates_applnote_1005-1pdf Accessed Accessed 2013 May 24.
88. Heitland P, Koster HD, (2006) Biomonitoring of 37 trace elements in blood samples from inhabitants of northern Germany by ICP-MS. J Trace Elem Med Bio 20: 253-262.
89. Benkhedda K, Infante HG, Ivanova E, Adams FC, (2000) Trace metal analysis of natural waters and biological samples by axial inductively coupled plasma time of flight mass spectrometry (ICP-TOFMS) with flow injection on-line adsorption preconcentration using a knotted reactor. J Anal Atom Spectrom 15: 1349-1356.
90. Harborne JB (1988) The Flavonoids. London: Chapman & Hall. 531 p.
91. Kuimierek K, Bald E, (2008) Measurement of reduced and total mercaptamine in urine using liquid chromatography with ultraviolet detection. Biomed Chromatogr 22: 441-445.
92. Kusmierek K, Chwatko G, Bald E, (2008) Redox status of main urinary sulfur fmino acids evaluation by liquid chromatography. Chromatographia 68: S91-S95.
93. Kusmierek K, Glowacki R, Bald E, (2006) Analysis of urine for cysteine, cysteinylglycine, and homocysteine by high-performance liquid chromatography. Anal Bioanal Chem 385: 855-860.
94. Moure A, Cruz JM, Franco D, Dominguez JM, Sineiro J, et al. (2001) Natural antioxidants from residual sources. Food Chem 72: 145-171.
95. Woo KL, Lee DS, (1995) Capillary gas-chromatographic determination of proteins and biological amino-acids as n(o)-tert-butyldimethylsilyl derivatives. J Chromatogr B Biomed Appl 665: 15-25.
96. Holmes E, Loo RL, Cloarec O, Coen M, Tang HR, et al. (2007) Detection of urinary drug metabolite (Xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. Anal Chem 79: 2629-2640.
97. Zhang QF, Wysocki VH, Scaraffia PY, Wells MA, (2005) Fragmentation pathway for glutamine identification: Loss of 73 Da from dimethylformamidine glutamine isobutyl ester. J Am Soc Mass Spectr 16: 1192-1203.
98. Corso G, Esposito M, Gallo M, Dellorusso A, Antonio M, (1993) Transformation of arginine into ornithine during the preparation of Its tert-butyldimethylsilyl derivative for analysis by gas chromatography/mass spectrometry. Biol Mass Spectrom 22: 698-702.
99. Arthur CL, Pawliszyn J, (1990) Solid-phase microextraction with thermal-desorption using fused-silica optical fibers. Anal Chem 62: 2145-2148.
100. Jia CR, Luo YZ, Pawliszyn J, (1998) Solid phase microextraction combined with HPLC for determination of metal ions using crown ether as selective extracting reagent. J Microcolumn Sep 10: 167-173.
101. Cava-Montesinos P, Nilles K, Cervera ML, de la Guardia M, (2005) Non-chromatographic speciation of toxic arsenic in fish. Talanta 66: 895-901.
102. Franke AA, Custer LJ, (1994) High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr B Biomed Appl 662: 47-60.
103. Franke AA, Custer LJ, Wang W, Shi CY, (1998) HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217: 263-273.
104. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM, (1993) Homocysteine and other thiols in plasma and urine- automated-determination and sample stability. Clin Chem 39: 263-271.
105. David FP (1971) Composition and concentrative properties of human urine. Washington: National Aeronautics and Space Administration. 107 p.
106. Gates SC, Sweeley CC, Krivit W, Dewitt D, Blaisdell BE, (1978) Automated metabolic profiling of organic-acids in human Urine.2. analysis of urine samples from healthy adults, sick children, and children with neuroblastoma. Clin Chem 24: 1680-1689.
107. Hoffmann G, Aramaki S, Blumhoffmann E, Nyhan WL, Sweetman L, (1989) Quantitative-analysis for organic-acids in biological samples- batch isolation followed by gas chromatographic-mass Spectrometric analysis. Clin Chem 35: 587-595.
108. Liebich HM, Forst C, (1990) Basic profiles of organic-acids in urine. J Chromatogr-Biomed 525: 1-14.
109. Matsumoto I, Kuhara T, (1996) A new chemical diagnostic method for inborn errors of metabolism by mass spectrometry- Rapid, practical, and simultaneous urinary metabolites analysis. Mass Spectrom Rev 15: 43-57.
110. Goulle JP, Mahieu L, Castermant J, Neveu N, Bonneau L, et al. (2005) Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair- Reference values. Forensic Sci Int 153: 39-44.
111. Guo K, Li L, (2009) Differential C-12/C-13-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem 81: 3919-3932.
112. Shaykhutdinov RA, MacInnis GD, Dowlatabadi R, Weljie AM, Vogel HJ, (2009) Quantitative analysis of metabolite concentrations in human urine samples using C-13{H-1} NMR spectroscopy. Metabolomics 5: 307-317.
113. Kvitvang HFN, Andreassen T, Adam T, Villas-Boas SG, Bruheim P, (2011) Highly Sensitive GC/MS/MS Method for Quantitation of Amino and Nonamino Organic Acids. Anal Chem 83: 2705-2711.
114. Silva CL, Passos M, Camara JS, (2011) Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Brit J Cancer 105: 1894-1904.
115. Guo K, Peng J, Zhou RK, Li L, (2011) Ion-pairing reversed-phase liquid chromatography fractionation in combination with isotope labeling reversed-phase liquid chromatography-mass spectrometry for comprehensive metabolome profiling. J Chromatogr A 1218: 3689-3694.
116. Saude EJ, Skappak CD, Regush S, Cook K, Ben-Zvi A, et al. (2011) Metabolomic profiling of asthma: Diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immun 127: 757-U408.
117. Zhang SC, Liu LY, Steffen D, Ye T, Raftery D, (2012) Metabolic profiling of gender: Headspace-SPME/GC-MS and H-1 NMR analysis of urine. Metabolomics 8: 323-334.
118. van der Kloet FM, Tempels FWA, Ismail N, van der Heijden R, Kasper PT, et al. (2012) Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics 8: 109-119.
119. Cheng Y, Xie GX, Chen TL, Qiu YP, Zou X, et al. (2012) Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 11: 1354-1363.
120. Rocha SM, Caldeira M, Carrola J, Santos M, Cruz N, et al. (2012) Exploring the human urine metabolomic potentialities by comprehensive two-dimensional gas chromatography coupled to time of flight mass spectrometry. J Chromatogr A 1252: 155-163.